Quarterly report [Sections 13 or 15(d)]

Balance Sheet Components (Tables)

v3.25.3
Balance Sheet Components (Tables)
9 Months Ended
Sep. 30, 2025
Balance Sheet Components [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets as of December 31, 2024 and September 30, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2024     2025  
             
Prepaid directors’ and officers’ liability insurance premiums   $ 263     $ 489  
Prepaid drug manufacturing supply costs     3,572       6,222  
Other     971       881  
Total   $ 4,806     $ 7,592  
Schedule of Property, Plant and Equipment

Property and equipment as of December 31, 2024 and September 30, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2024     2025  
             
Leasehold improvements   $ 49     $ 65  
Lab equipment     26       26  
Furniture and fixtures     39       47  
Subtotal     114       138  
Less accumulated depreciation     (39 )     (63 )
Net   $ 75     $ 75  
Schedule of Accounts Payable

Accounts payable as of December 31, 2024 and September 30, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2024     2025  
             
Trade accounts payable   $ 966     $ 717  
Credit card liability     92       240  
Total   $ 1,058     $ 957  
Schedule of Accrued Liabilities

Accrued liabilities as of December 31, 2024 and September 30, 2025 consisted of the following (in thousands):

 

    As of     As of  
    December 31,     September 30,  
    2024     2025  
             
Accrued labor costs   $ 1,910     $ 1,626  
Accrued drug development costs     1,258       730  
Other     394       406  
Total   $ 3,562     $ 2,762